Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea:: a systematic review

被引:231
作者
Thomas, C [1 ]
Stevenson, M
Riley, TV
机构
[1] Univ Western Australia, Queen Elizabeth II Med Ctr, Sch Biomed & Chem Sci, Perth, WA 6009, Australia
[2] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia
[3] W Australian Ctr Pathol & Med Res, Div Microbiol, Perth, WA 6009, Australia
关键词
Clostridium difficile; systematic review;
D O I
10.1093/jac/dkg254
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A systematic review of studies that investigated the association of antibiotics with hospital-acquired Clostridium difficile-associated diarrhoea (CDAD) was undertaken to summarize the strength of the evidence for this relationship. The results from the studies identified were considered after critically reviewing the design and conduct of each study. Although the majority of studies found an association with various antibiotics, antibiotic classes or components of antibiotic administration, most were limited in their ability to establish a causal relationship by the use of incorrect control groups, the presence of bias, inadequate control of confounding and small sample sizes. The limitations identified in this review prevented the pooling of results in a meta-analysis. Two studies of reasonable quality suggested an association between clindamycin, cephalosporins, penicillins and CDAD. Well-designed studies grounded in epidemiological principles are needed to identify true risk factors for CDAD and to provide reliable estimates of the strength of association.
引用
收藏
页码:1339 / 1350
页数:12
相关论文
共 78 条
[31]  
GRUBE BJ, 1987, ARCH SURG-CHICAGO, V122, P655
[32]   Clarithromycin appears to be linked with Clostridium difficile-associated diarrhoea in the elderly [J].
Guyot, A ;
Rawlins, MDM ;
Barrett, SP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (04) :642-643
[33]   What is an appropriate control group to identify risk factors for Clostridium difficile-associated diarrhoea? [J].
Guyot, A ;
Barrett, SP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (05) :747-748
[34]  
Halim HA, 1997, J CLIN PHARM THER, V22, P391
[35]   Antibiotic prophylaxis and the risk of Clostridium difficile-associated diarrhoea [J].
Harbarth, S ;
Samore, MH ;
Carmeli, Y .
JOURNAL OF HOSPITAL INFECTION, 2001, 48 (02) :93-97
[36]   Determination and validation of a predictive model for Clostridium difficile diarrhea in hospitalized oncology patients [J].
Hornbuckle, K ;
Chak, A ;
Lazarus, HM ;
Cooper, GS ;
Kutteh, LA ;
Gucalp, R ;
Carlisle, PS ;
Sparano, J ;
Parker, P ;
Salata, RA .
ANNALS OF ONCOLOGY, 1998, 9 (03) :307-311
[37]   RISK-FACTORS FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHEA IN HIV-INFECTED PATIENTS [J].
HUTIN, Y ;
MOLINA, JM ;
CASIN, I ;
DAIX, V ;
SEDNAOUI, P ;
WELKER, Y ;
LAGRANGE, P ;
DECAZES, JM ;
MODAI, J .
AIDS, 1993, 7 (11) :1441-1447
[38]   INCREASED RISK OF DIARRHEA CAUSED BY CLOSTRIDIUM-DIFFICILE IN ELDERLY PATIENTS RECEIVING CEFOTAXIME [J].
IMPALLOMENI, M ;
GALLETLY, NP ;
WORT, SJ ;
STARR, JM ;
ROGERS, TR .
BRITISH MEDICAL JOURNAL, 1995, 311 (7016) :1345-1346
[39]   RISK-FACTORS FOR CLOSTRIDIUM-DIFFICILE STOOL CYTOTOXIN-B AMONG CRITICALLY ILL PATIENTS - ROLE OF SUCRALFATE [J].
JENSEN, GL ;
BROSS, JE ;
BOURBEAU, PP ;
NAUMOVITZ, DW ;
STREATER, M ;
GIANFERANTE, LE .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (01) :227-230
[40]   NOSOCOMIAL CLOSTRIDIUM-DIFFICILE COLONIZATION AND DISEASE [J].
JOHNSON, S ;
CLABOTS, CR ;
LINN, FV ;
OLSON, MM ;
PETERSON, LR ;
GERDING, DN .
LANCET, 1990, 336 (8707) :97-100